Short-term intense Bcr-Abl kinase inhibition with nilotinib is adequate to trigger cell death in BCR-ABL+ cells

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)
Original languageEnglish
Pages (from-to)1205-1206
Number of pages2
JournalLeukemia
Volume23
Issue number6
DOIs
Publication statusPublished or Issued - 2009

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this